Stem Cell Therapy for Hair Loss | Hair Loss Treatment in India Stem Cell Therapy for Hair Loss - Enhances hair regrowth within 2-3 weeks after treatment! By: AllHairSolution … Continue reading →

Stem Cell 15 By: Jennifer Etter … Continue reading →

In 2004, with President George W. Bush dead set against stem cell research, California just went ahead and did it. Voters made stem cell research a state constitutional right, and endorsed $3 billion in bond sales for 10 years to cement the deal. CIRM, the California Institute for Regenerative Medicine created under Proposition 71, has become a world center for stem cell research, and its president is Australian Alan Trounson, a pioneer in in vitro fertilization. As Proposition 71 approaches its 10-year anniversary, Trounson offers a prognosis. Q: It's been almost 10 years since California funded what may be the world's biggest stem cell research program. What are you up to? A: We are working hard to get six or seven projects to clinical trials. We have more than 70 (total) programs moving (toward) clinical trials. It's a lot of work to chaperon. I'll give you three examples: one, linking genetics, or genomics work, to stem cells, integrating the two. We're going to create a center in California that will bring a lot of (genetics) studies and clinical work to a new level. Secondly, we've set up a structure for banking the 3,000 cell lines from "induced pluripotent stem cells" … Continue reading →

Boca Raton, FL (PRWEB) May 31, 2013 The Institute of Regenerative and Molecular Orthopaedics (IRMO), world-renowned stem cell therapy experts, expand sports medicine advances with their expertise at stem cell and PRP (platelet rich plasma) therapy. As pioneers in stem cell and PRP therapy, the IRMO has introduced to the world what may be some of the biggest breakthroughs in sports medicine and beyond. This comes as good news to athletes everywhere suffering from various injures who are seeking state-of-the-art medical solutions. The Institute of Regenerative and Molecular Orthopaedics is one of the few orthopedic practices in the world that utilizes stem cell and PRP therapy with orthopedic surgery. Headed by Dr. Joseph Purita, the world-renowned stem cell treatment pioneer, the IRMO has been making waves in the sports medicine community for years with their groundbreaking procedures. Dr. Purita has treated thousands of patients from around the world with tremendous success. Dr. Purita and his staff use stem cell and PRP therapy to treat conditions ranging from basic tennis elbow problems, to degenerative arthritis afflicting major joints and more. The injection of stem cells for its advanced rejuvenation and repair qualities is still in limited use in sports medicine. For … Continue reading →

The oral drug Valium also known by its generic name, diazepam was once popular with doctors in the 1970s as a treatment for seizures brought on by epilepsy. However, the drug, also used to treat anxiety, has fallen out of favor in recent years as it is prone to abuse and often dangerous if taken in high doses. Now, in light of a recent study, the need for Valium to treat epilepsy may be even further diminished. Researchers from Stanford University School of Medicine have discovered a naturally occurring protein in the brains of mammals that acts like Valium, stopping certain types of seizures from occurring. Researchers hope that if they are able to discover a way to boost this protein naturally, doctors would no longer have a need to prescribe Valium. The protein, identified as diazepam binding inhibitor (DBI), essentially acts like the brains very own brake system, sensing when a seizure is about to occur and arresting the process before it can spiral out of control. Our thinking on brain circuits and epilepsy has been that our brains have their own ways to control seizures, and this is why most of us arent having seizures every day, study … Continue reading →

May 31, 2013 5:47 am by Staff | 0 Comments MedCity News LONDON (Reuters) - Use of an epilepsy drug developed by GlaxoSmithKline and Valeant Pharmaceuticals should be restricted to patients for whom other anti-epileptic medicines have proved inadequate or not tolerated, EU regulators said on Friday. The European Medicines Agency said the move followed cases of abnormal coloring of the skin, nails, lips and eye tissues, including the retina, in some patients who took Trobalt. It recommended a comprehensive eye examination should be performed at the start of treatment and at least every six months during treatment. Among 55 patients receiving Trobalt in long-term studies examined so far, 15 had retinal pigmentation, the agency added. Abnormal coloring of the retina can result in impaired vision. The Food and Drug Administration issued a similar warning about the drug - which is sold in the United States as Potiga - last month. (Reporting by Ben Hirschler) Follow this link: GSK, Valeant epilepsy drug can impact eye tissue, EU agency warns … Continue reading →